Dr. Berardi is Section Head of complex Malignant Hematopathology at the Ottawa Hospital, and Associate Professor of Pathology in the Faculty of Medicine at the University of Ottawa. He is the current chair of the Hematopathology Interest Group within the Canadian Leukemia Study Group (CLSG) and executive within the Canadian Association of Pathologists (CAP-ACP) Section on Hematopathology.
His research interests include diagnostic and prognostic markers in non-Hodgkin lymphoma, acute leukemia and plasma cell disorders, and molecular diagnosis of leukemia and lymphoma. He participates in numerous multi-institutional research efforts including active collaborations with the Ontario Molecular Pathology Research Network (OMPRN) and the Ontario Institute for Cancer Research (OICR). Dr. Berardi is a regular contributor to guidelines issued through the Cancer Care Ontario (CCO) – Program in Evidence-Based Care (PEBC).
Clarke G, Hannon J, Berardi P, Barr G, Cote J, Fallis R, Alport T, Lane D, Petraszko T, Ochoa G, Goldman M. Resolving variable maternal D typing using serology and genotyping in selected prenatal patients. Transfusion. 2016 Dec;56(12):2980-2985. doi: 10.1111/trf.13798. Epub 2016 Sep 9.
Berardi P, Bessette E, Ng M, Angus N, Lane D, Gariepy L, Pavenski K, Ochoa-Garay G, Cote J, Goldman M. Weak D type 67 in four related Canadian blood donors. Immunohematology. 2015;31(4):159-62.
Padmore R, Berardi P, Erickson K, Desjardins D, Giulivi A, Tokessy M, Neurath D, Saidenberg E. Acute extravascular haemolytic transfusion reaction due to Anti-Kpa antibody missed by electronic crossmatch. Transfusion and Apheresis Science. 2014 Aug 15. S1473-0502(14)00150-5 [Epub ahead of print].
Samiee S, Berardi P, Bouganim N, Vandermeer L, Arnaout A, Mirsky D, Chasen M, Dent S, Caudrelier J, Clemons M. Excision of the primary tumour in patients with metastatic breast cancer: A Clinical Dilemma. Current Oncology. 2012 Aug; 19(4): 270-279.
Feki A, Berardi P, Bellingan G, Major A, Krause K, Petignat P, Zehra R, Pervaiz S, Irminger-Finger I. Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model. Critical Reviews in Oncology Hematology. 2009 Oct; 72(1):1-9.
Berardi P, Soliman MA, Pastyryeva S, Bonnefin P, Feng X, Colina A, Young D and Riabowol K. ING1a expression increases during replicative senescence and induces a senescent phenotype. Aging Cell. 2008 Dec; 7(6):783-94.
Russell M, Berardi P and Riabowol K. Grow-ING, Age-ING, and Die-ING: ING proteins link cancer, senescence and apoptosis. Experimental Cell Research. 2006 Apr 15; 312(7):951-61. Epub 2006 Mar 3.
Han X, Berardi P, Riabowol K. Chromatin modification and senescence: linkage by tumor suppressors? Rejuvenation Res. 2006 Spring; 9(1):69-76.
Feki A, Jefford C, Berardi P, Krause K and Irminger-Finger I. BARD1 induces apoptosis by catalyzing phosphorylation of p53 by DNA-damage response kinase. Oncogene. 2005 May 26; 24(23):3726-36.
Berardi P, Russell M, El-Osta A and Riabowol K. Functional links between transcription, DNA repair and apoptosis. Cellular and Molecular Life Sciences. 2004 Sept; 61(17):2173-80.
Berardi P, Meyyappan M and Riabowol K. A novel transcriptional inhibitory element differentially regulates the cyclin D1 gene in senescent cells. Journal of Biological Chemistry. 2003 Feb 28; 278(9):7510-9.
